Press release
Impact Of Rising Chronic Eye Conditions On Vision Loss And Treatment Demand: Major Factor in the Transformation of the Glaucoma Market in 2025
Mobile Application Optimization Software Market Size
The dimension of the glaucoma market has seen significant expansion in past years. The market, set to escalate from $7.76 billion in 2024 to $8.22 billion in 2025, demonstrates a compound annual growth rate (CAGR) of 5.9%. Factors contributing to this growth during the historic period include enhanced eye health consciousness, amplified healthcare expenditure, the rising use of telemedicine in eye care, growth in healthcare infrastructure, and government initiatives to improve healthcare.
In the upcoming years, the glaucoma market size is forecasted to experience robust expansion, escalating to $10.20 billion in 2029 with a compound annual growth rate (CAGR) of 5.5%. The growth during the prediction period is credited to factors like an increasing elderly population, the escalating occurrence of glaucoma, surging demand for less invasive surgeries, an increase in diabetes cases, and a rise in hypertension. Key trends for the forecast period encompass progress in diagnostic technology, introduction of novel drug therapies, technological breakthroughs in surgical equipment, the presence of combination treatments, and the acceptance of robot-assisted surgeries.
What Key Elements Are Boosting Growth in the Glaucoma Market?
The growth of the glaucoma market is anticipated to be propelled by the increasing incidence of chronic eye diseases. Chronic eye diseases are enduring disorders that affect the eyes, often causing sustained visual impairment or discomfort and demand constant management or treatment. The rising occurrence of chronic eye diseases can be attributed to aging populations, an increase in screen time, lifestyle factors, and an increased frequency of conditions such as diabetes and hypertension. Glaucoma treatment is necessary to reduce intraocular pressure, avert further damage to the optic nerve, and save vision, as unchecked glaucoma can lead to irreversible blindness. For example, as reported by the National Health Service (NHS), a publicly funded healthcare platform in the UK, in December 2024, over 2 million individuals in the UK are experiencing sight loss in 2024. Moreover, the tally of people living with sight loss is foreseen to increase by 27%, hitting approximately 2.8 million by 2035. Hence, the escalating incidence of chronic eye conditions is fueling the glaucoma market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20820&type=smp
Who Are the Major Industry Players Fueling Glaucoma Market Expansion?
Major companies operating in the glaucoma market are Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceuticals Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Bausch & Lomb Corp., Carl Zeiss Meditec, Santen Pharmaceuticals Co. Ltd., Topcon Corporation, Thea Laboratoires, Corza Ophthalmology, Lumenis Ltd., Alcon Inc., Viva BioInnovator, Glaukos Corporation, Iridex Corporation, Nova Eye Medical Ltd., Renova Life Sciences Private Limited, Qlaris Bio Inc., PolyActiva Pty Ltd., Nidek Co. Ltd., Haag-Streit AG
What Are the Emerging Trends in the Glaucoma Industry?
Key players in the glaucoma market are directing their efforts towards the creation of pioneering treatments like Rho-kinase (ROCK) inhibitors. These drugs offer two-pronged benefits: they enhance the flow of aqueous humor and relax trabecular meshwork cells, both fundamental processes in mitigating glaucoma. ROCK inhibitors interfere with Rho-kinase enzymes that regulate cell contraction, thus reducing intraocular pressure, a key element in managing glaucoma. Case in point, in July 2023, Santen Pharmaceutical Co. Ltd., a Japanese firm specializing in eye health products, introduced Roclanda in the UK. This medication combines latanoprost and netarsudil, a new ROCK inhibitor, into a fixed-dose treatment that tackles intraocular pressure (IOP) by dealing with issues in the trabecular meshwork. It's intended for adults with primary open-angle glaucoma or ocular hypertension, whose IOP hasn't been sufficiently reduced by a single-drug treatment of either prostaglandin or netarsudil. Roclanda's emergence in Europe represents the inaugural new category of glaucoma drugs in a quarter-century, marking a significant advancement in treatment solutions. Owing to the amalgamation of netarsudil and latanoprost, Roclanda enhances the flow along both the conventional (trabecular) and unconventional (uveoscleral) routes, thus offering a comprehensive strategy in the management of elevated IOP.
How Is the Segmentation of the Glaucoma Market Defined?
The glaucoma market covered in this report is segmented -
1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types
2) By Diagnosis: Tonometry, Ophthalmoscopy, Perimetry, Gonioscopy
3) By Drug Class: Beta Blockers, Prostaglandins, Alpha Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Combination Drugs, Other Drug Classes
4) By Administration: Oral, Injections, Intravitreal, Other Administrations
5) By End-User: Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Open Angle Glaucoma: Primary Open Angle Glaucoma (POAG), Secondary Open Angle Glaucoma
2) By Angle Closure Glaucoma: Primary Angle Closure Glaucoma, Secondary Angle Closure Glaucoma
3) By Other Disease Types: Normal-Tension Glaucoma, Pigmentary Glaucoma, Pseudoexfoliative Glaucoma, Congenital Glaucoma
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/glaucoma-global-market-report
What Is the Leading Region in the Glaucoma Market?
North America was the largest region in the glaucoma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glaucoma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Glaucoma Global Market Report?
- Market Size Analysis: Analyze the glaucoma Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the glaucoma Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall glaucoma market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the glaucoma market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20820
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact Of Rising Chronic Eye Conditions On Vision Loss And Treatment Demand: Major Factor in the Transformation of the Glaucoma Market in 2025 here
News-ID: 3877944 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Glaucoma
Glaucoma Surgery Devices Market Report 2024 - Glaucoma Surgery Devices Market Si …
"The Business Research Company recently released a comprehensive report on the Global Glaucoma Surgery Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The glaucoma surgery devices…
Global Glaucoma Market
According to a new market research report published by Global Market Estimates, the Global Glaucoma Market is projected to grow at a CAGR value of 5.0% from 2023 to 2028.
Growing awareness for early diagnosis of glaucoma have gained prominence due to various educational campaigns and screening programs. Early detection allows for timely intervention, leading to better disease management and reducing the risk of vision loss, thus propelling the market growth.…
Glaucoma Treatment Market - Safeguarding Sight: Innovating Glaucoma Treatment fo …
Newark, New Castle, USA: The "Glaucoma Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Glaucoma Treatment Market: https://www.growthplusreports.com/report/glaucoma-treatment-market/8926
This latest report researches the industry structure, sales, revenue,…
Glaucoma Surgical Devices Market By Device Type (Glaucoma Drainage Devices, Impl …
Glaucoma Surgical Devices market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain…
Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the…
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide.
Sudden increase in the aging population and…
